Diabetes
Conditions
Interventions
Control group (short-term experiment):Wear VR headset to experience a VR room that does not contain biophilic design elements.
Intervention group A:Wear VR headset to experience a VR room that contains designs featuring A.
Intervention group B:Wear VR headset to experience a VR room that contains designs featuring B.
Intervention group C:Wear VR headset to experience a VR room that contains designs featuring C
Intervention group A+B:Wear VR headset to experience a VR room that contains designs featuring A and B
Intervention group A+C:Wear VR headset to experience a VR room that contains designs featuring A and C
Intervention group B+C:Wear VR headset to experience a VR room that contains designs featuring B and C
Intervention group A+B+C:Wear VR headset to experience a VR room that contains designs featuring A, B, and C.
Control group (long-term experiment):Guidance on healthy behaviors
Intervention group (long-term experiment):Biophilic living environments combined with guidance on healthy behaviors
Sponsors
Capital Medical University
Eligibility
Sex/Gender
All
Age
60 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Patients with type 2 diabetes (T2DM) diagnosed by a secondary or higher hospital or those who regularly take hypoglycemic drugs at baseline; 2. Aged >= 60 years; 3. Sign the informed consent. 4. Absence of biophilic design elements in the living environment at baseline (only for the long-term experiment).
Exclusion criteria
Exclusion criteria: 1. Serious mental illnesses such as schizophrenia and hysteria; 2. Patients with diagnosed dementia, cognitive impairment, severe physical disabilities, language disorders who are unable to cooperate with questionnaire surveys or physical examinations; 3. Cognitive impairments caused by diseases such as Parkinson's disease, multiple sclerosis, brain trauma, stroke, epilepsy, and intracranial space-occupying lesions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive function score;Cognitive function score (long-term experiment);Serum biomarker p-tau181 (long-term experiment);Serum biomarker esRAGE (long-term experiment);Serum biomarker IL-6 (long-term experiment); | — |
Secondary
| Measure | Time frame |
|---|---|
| Heart rate;Blood pressure;Evaluation of VR environments;Psychological health status (long-term experiment);Sleep status (long-term experiment);Physical activity conditions (long-term experiment);Blood pressure (long-term experiment); | — |
Countries
China
Contacts
Public ContactLiu Kuo
School of Public Health, Capital Medical University
Outcome results
None listed